Bone kidney interactions
- PMID: 26156535
- DOI: 10.1007/s11154-015-9314-3
Bone kidney interactions
Abstract
The fact that bone disease and kidney disease co-exist is well known. Formally, this inter-relationship is called chronic kidney disease mineral bone disorder or CKD-MBD. Traditionally, it was thought that bone played a passive role in CKD-MBD - specifically that kidney disease caused disordered mineral metabolism which resulted in bone disease and ultimately fractures. More recently however our understanding of bone function in general and the role that bone plays in CKD-MBD in particular, has changed. This chapter will briefly review epidemiology of fractures in chronic kidney disease (CKD) and the roles that imaging and measuring markers of mineral metabolism can play in assessing fracture risk. We will then review more recent data consistent with the concept MBD occurs early in the course of CKD and, via the secretion of novel molecules and/or signalling pathways, the bone can influence other organ systems.
Similar articles
-
[Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].Clin Calcium. 2016 Feb;26(2):259-67. Clin Calcium. 2016. PMID: 26813506 Review. Japanese.
-
An introduction to CKD-MBD research: restart for the future.Clin Exp Nephrol. 2017 Mar;21(Suppl 1):1-3. doi: 10.1007/s10157-016-1372-7. Clin Exp Nephrol. 2017. PMID: 28083765 No abstract available.
-
Women and CKD-mineral and bone disorder.Adv Chronic Kidney Dis. 2013 Sep;20(5):423-6. doi: 10.1053/j.ackd.2013.06.007. Adv Chronic Kidney Dis. 2013. PMID: 23978548 Review.
-
Chronic kidney disease and fragility fracture.Clin Exp Nephrol. 2017 Mar;21(Suppl 1):46-52. doi: 10.1007/s10157-016-1368-3. Epub 2016 Dec 23. Clin Exp Nephrol. 2017. PMID: 28012057 Free PMC article. Review.
-
Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.Int J Mol Sci. 2020 Sep 18;21(18):6846. doi: 10.3390/ijms21186846. Int J Mol Sci. 2020. PMID: 32961953 Free PMC article.
Cited by
-
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide.Int J Nephrol Renovasc Dis. 2016 Feb 2;9:11-9. doi: 10.2147/IJNRD.S78040. eCollection 2016. Int J Nephrol Renovasc Dis. 2016. PMID: 26893577 Free PMC article. Review.
-
Thyroid and bone turnover markers in type 2 diabetes: results from the METAL study.Endocr Connect. 2022 Mar 31;11(3):e210484. doi: 10.1530/EC-21-0484. Endocr Connect. 2022. PMID: 35196256 Free PMC article.
-
FGF-2 suppresses expression of nephronectin via JNK and PI3K pathways.FEBS Open Bio. 2018 Apr 19;8(5):836-842. doi: 10.1002/2211-5463.12421. eCollection 2018 May. FEBS Open Bio. 2018. PMID: 29744297 Free PMC article.
-
Evaluation of fracture risk in chronic kidney disease.J Nephrol. 2017 Oct;30(5):653-661. doi: 10.1007/s40620-017-0398-6. Epub 2017 Apr 6. J Nephrol. 2017. PMID: 28386879 Review.
-
X-linked hypophosphatemia and growth.Rev Endocr Metab Disord. 2017 Mar;18(1):107-115. doi: 10.1007/s11154-017-9408-1. Rev Endocr Metab Disord. 2017. PMID: 28130634 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources